Adamek RJ et al. |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection. |
1995 |
Am. J. Gastroenterol. |
pmid:7801936
|
|
FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11363096
|
Weits J and Sprenger HG |
[Surgical treatment of lymphadenitis caused by non-tuberculous mycobacteria in children]. |
1995 |
Ned Tijdschr Geneeskd |
pmid:8524431
|
Ishii K et al. |
A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters. |
1995 |
Biol. Pharm. Bull. |
pmid:7550125
|
Harris AW et al. |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605863
|
Katelaris PH et al. |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605864
|
Yousfi MM et al. |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605865
|
Forné M et al. |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. |
1995 |
Am. J. Gastroenterol. |
pmid:7733075
|
Tebas P et al. |
Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. |
1995 |
Clin. Infect. Dis. |
pmid:7742453
|
Moayyedi P et al. |
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574714
|
Fujioka T et al. |
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574733
|
Deltenre M et al. |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574734
|
Fukuda Y et al. |
Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574735
|
Pavlopoulou J et al. |
Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children. |
1995 |
J Chemother |
pmid:8904139
|
Raffi F et al. |
Breakthrough cerebral toxoplasmosis in patients with AIDS who are being treated with clarithromycin. |
1995 |
Clin. Infect. Dis. |
pmid:7795062
|
Sharma PK and Tami TA |
AIDS: lessons from the last decade and prospects for the future. |
1995 |
Ear Nose Throat J |
pmid:7796740
|
Cama VA et al. |
Treatment of acute and chronic Cryptosporidium parvum infections in mice using clarithromycin and 14-OH clarithromycin. |
1994 Sep-Oct |
J. Eukaryot. Microbiol. |
pmid:7804227
|
O'Connor NK and Fris J |
Clarithromycin-carbamazepine interaction in a clinical setting. |
1994 Nov-Dec |
J Am Board Fam Pract |
pmid:7847111
|
Scaglione F et al. |
Effect of antibiotics on Bordetella pertussis adhering activity: hypothesis regarding mechanism of action. |
1994 May-Jun |
Chemotherapy |
pmid:7515782
|
Gersema LM et al. |
Suspected drug interaction between cyclosporine and clarithromycin. |
1994 Mar-Apr |
J. Heart Lung Transplant. |
pmid:8031821
|
Heifets LB |
Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy. |
1994 Mar-Apr |
Res. Microbiol. |
pmid:7809471
|
Dautzenberg B |
Clinical trials in Mycobacterium avium therapy: lessons to take home. |
1994 Mar-Apr |
Res. Microbiol. |
pmid:7809472
|
Winter J |
Intravenous clarithromycin. |
1994 Mar 16-Apr 5 |
Br J Hosp Med |
pmid:8032567
|
Mor N et al. |
Accumulation of clarithromycin in macrophages infected with Mycobacterium avium. |
1994 Jan-Feb |
Pharmacotherapy |
pmid:8159593
|
Tessier MH et al. |
Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children. |
1994 Dec 24-31 |
Lancet |
pmid:7997032
|
Darling TN et al. |
Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin. |
1994 |
Br. J. Dermatol. |
pmid:7918014
|
Domschke W |
Omeprazole, Helicobacter pylori, and gastritis. |
1994 |
J. Gastroenterol. |
pmid:7921141
|
Geraci AJ |
Empiric antibiotics in sinusitis. |
1994 |
Arch Fam Med |
pmid:7921288
|
Rust GS |
Multicenter comparison of clarithromycin and amoxicillin. |
1994 |
Arch Fam Med |
pmid:7921290
|
Sano M et al. |
[Inhibition of biofilm formation by clarithromycin (CAM) in an experimental model of complicated bladder infection--in vitro study using automated simulation of urinary antimicrobial concentration]. |
1994 |
Kansenshogaku Zasshi |
pmid:7829898
|
Sieber CC et al. |
[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?]. |
1994 |
Schweiz Med Wochenschr |
pmid:8091165
|
Dorrell L et al. |
Toxicity of clarithromycin in the treatment of Mycobacterium avium complex infection in a patient with AIDS. |
1994 |
J. Antimicrob. Chemother. |
pmid:7868416
|
Labenz J and Stolte M |
[Current therapy of Helicobacter pylori infection]. |
1994 |
Leber Magen Darm |
pmid:8145628
|
Logan RP et al. |
Eradication of Helicobacter pylori with clarithromycin and omeprazole. |
1994 |
Gut |
pmid:8150340
|
Neri M et al. |
Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:7986974
|
|
[Recent advances in macrolide antibiotics: focused on clarithromycin. Discussion]. |
1994 |
Jpn J Antibiot |
pmid:7990251
|
Alder J et al. |
Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole. |
1994 |
J. Antimicrob. Chemother. |
pmid:8182006
|
Tsang KW et al. |
The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration. |
1994 |
J. Antimicrob. Chemother. |
pmid:8182010
|
Sundberg L and Cederberg A |
Penetration of clarithromycin and its 14-hydroxy metabolite into middle ear effusion in children with secretory otitis media. |
1994 |
J. Antimicrob. Chemother. |
pmid:8182011
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
|
[Zeclar, a new antibiotic (clarithromycin 250 mg from Abbott laboratories]. |
1994 |
Rev Infirm |
pmid:7652424
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Yoshida K et al. |
Chlamydia trachomatis infection in the semen of asymptomatic infertile men: detection of the antigen by in situ hybridization. |
1994 |
Urol. Int. |
pmid:7855940
|
Laing RB et al. |
New antimicrobials against Mycobacterium marinum infection. |
1994 |
Br. J. Dermatol. |
pmid:7857853
|
Spiegl PV and Feiner CM |
Mycobacterium phlei infection of the foot: a case report. |
1994 |
Foot Ankle Int |
pmid:7894643
|
Walker KJ et al. |
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811010
|
Price DA et al. |
Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole. |
1994 |
J. Antimicrob. Chemother. |
pmid:7814298
|
Tahara RW et al. |
The question of clarithromycin: a first-line drug for sinusitis? |
1994 |
Arch Fam Med |
pmid:7818657
|
Pustorino S et al. |
[Effects of intravenous administration of clarithromycin on plasma levels of gastrin and group I pepsinogen]. |
1994 |
Clin Ter |
pmid:7820984
|
Alder J et al. |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. |
1994 |
J. Acquir. Immune Defic. Syndr. |
pmid:7932081
|